1. Graham DY. What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates. Dig Dis Sci 2002;47:1665–1678.
2. de Groen PC, Lubbe DF, Hirsch LJ, et al. Esophagitis associated with the use of alendronate. N Engl J Med 1996;335:1016–1021.
3. Macedo G, Azevedo F, Ribeiro T. Ulcerative esophagitis caused by etidronate. Gastrointest Endosc 2001;53:250–251.
4. Lanas AI, Sousa FL, Ortego J, et al. Aspirin renders the oesophageal mucosa more permeable to acid and pepsin. Eur J Gastroenterol Hepatol 1995;7:1065–1072.
5. Katzka DA. Esophageal disorders caused by medications, trauma, and infection. In: Feldman M, Friedman LS, Brandt LJ, editors. Sleisenger and Fordtran’s gastrointestinal and liver disease: pathophysiology, diagnosis, management. Vol. 1. 11th ed. Philadelphia: Elsevier, 2020. p. 661–664.
7. Whitney B, Croxon R. Dysphagia caused by cardiac enlargement. Clin Radiol 1972;23:147–152.
9. Chisholm RC, Curry SB. Vincristine-induced dysphagia. South Med J 1978;71:1364–1365.
10. Wang WS, Chiou TJ, Liu JH, Fan FS, Yen CC, Chen PM. Vincristineinduced dysphagia suggesting esophageal motor dysfunction: a case report. Jpn J Clin Oncol 2000;30:515–518.
16. McCord GS, Clouse RE. Pill-induced esophageal strictures: clinical features and risk factors for development. Am J Med 1990;88:512–518.
20. Bar-Ad V, Leiby B, Witek M, et al. Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemotherapy. Am J Clin Oncol 2014;37:433–437.
21. Gervaz P, Morel P, Vozenin-Brotons MC. Molecular aspects of intestinal radiation-induced fibrosis. Curr Mol Med 2009;9:273–280.
23. Wang J, Zheng H, Sung CC, Richter KK, Hauer-Jensen M. Cellular sources of transforming growth factor-beta isoforms in early and chronic radiation enteropathy. Am J Pathol 1998;153:1531–1540.
25. Tanksley JP, Willett CG, Czito BG, Palta M. Acute and chronic gastrointestinal side effects of radiation therapy. In: Feldman M, Friedman LS, Brandt LJ, editors. Sleisenger and Fordtran’s gastrointestinal and liver disease: pathophysiology, diagnosis, management. Vol. 1. 11th ed. Philadelphia: Elsevier, 2020. p. 606–618.
27. Berthrong M, Fajardo LF. Radiation injury in surgical pathology. Part II. alimentary tract. Am J Surg Pathol 1981;5:153–178.
28. François A, Milliat F, Guipaud O, Benderitter M. Inflammation and immunity in radiation damage to the gut mucosa. Biomed Res Int 2013;2013:123241.
33. Sasso FS, Sasso G, Marsiglia HR, et al. Pharmacological and dietary prophylaxis and treatment of acute actinic esophagitis during mediastinal radiotherapy. Dig Dis Sci 2001;46:746–749.
36. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341–1346.
37. Milano MT, Constine LS, Okunieff P. Normal tissue tolerance dose metrics for radiation therapy of major organs. Semin Radiat Oncol 2007;17:131–140.
38. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109–122.
39. Maguire PD, Sibley GS, Zhou SM, et al. Clinical and dosimetric predictors of radiation-induced esophageal toxicity. Int J Radiat Oncol Biol Phys 1999;45:97–103.
40. Topkan E, Yavuz MN, Onal C, Yavuz AA. Prevention of acute radiation-induced esophagitis with glutamine in non-small cell lung cancer patients treated with radiotherapy: evaluation of clinical and dosimetric parameters. Lung Cancer 2009;63:393–399.
41. Gul K, Mehmet K, Meryem A. The effects of oral glutamine on clinical and survival outcomes of non-small cell lung cancer patients treated with chemoradiotherapy. Clin Nutr 2017;36:1022–1028.
44. Hoffman RS, Burns MM, Gosselin S. Ingestion of caustic substances. N Engl J Med 2020;382:1739–1748.
45. Poley JW, Steyerberg EW, Kuipers EJ, et al. Ingestion of acid and alkaline agents: outcome and prognostic value of early upper endoscopy. Gastrointest Endosc 2004;60:372–377.
46. Hollenbach M, Tünnemann J, Struck MF, et al. Endoscopic findings and outcome in caustic ingestion of acidic and alkaline agents in adults: a retrospective analysis. Medicine (Baltimore) 2019;98:e16729.
47. Zargar SA, Kochhar R, Mehta S, Mehta SK. The role of fiberoptic endoscopy in the management of corrosive ingestion and modified endoscopic classification of burns. Gastrointest Endosc 1991;37:165–169.